Showing Results for
From:PLoS ONE (Vol. 8, Issue 11) Peer-ReviewedIdentification of driver mutations in lung adenocarcinoma has led to development of targeted agents that are already approved for clinical use or are in clinical trials. Therefore, the number of biomarkers that will be...
From:Pharmacogenomics (Vol. 16, Issue 10) Peer-ReviewedAuthor(s): Raffaella Pasquale aff1 , Francesca Fenizia aff1 , Riziero Esposito Abate aff1 , Alessandra Sacco aff1 , Claudia Esposito aff1 , Laura Forgione aff1 , Anna Maria Rachiglio aff1 , Simona Bevilacqua aff2 ,...
From:The French Review (Vol. 85, Issue 2) Peer-ReviewedAbstract Only
From:BioMed Research InternationalPeer-ReviewedEpidermal growth factor receptor (EGFR) mutations in non-small-cell lung cancer (NSCLC) are predictive of response to treatment with tyrosine kinase inhibitors. Competitive Allele-Specific TaqMan PCR (castPCR) is a...
From:The French Review (Vol. 94, Issue 4) Peer-ReviewedIntroduction Salué par la critique et primé au Festival de Cannes, Les misérables de Ladj Ly s'est imposé comme l'un des films les plus marquants de 2019. Vingt-cinq ans après Mathieu Kassovitz, Ladj Ly filme lui aussi...
Choose how you want to be alerted when new results for your search become available.
Subscribe to Gale's RSS feed to get content delivered to your favorite RSS aggregator. Copy and paste the URL below into your reader:
Tell us where to send the alert and how often you want to receive it